| Authors: |
Marinescu AM; Roche Pharma Research and Early Development, NRD Biomarkers, Roche Innovation Center Basel, Basel, Switzerland., Machado V; Roche Pharma Research and Early Development, NRD Biomarkers, Roche Innovation Center Basel, Basel, Switzerland., Pagano G; Roche Pharma Research and Early Development, NRD Early Clinical Development, Roche Innovation Center Basel, Basel, Switzerland., Muelhardt NM; Roche Pharma Research and Early Development, NRD Portfolio Development, Roche Innovation Center Basel, Basel, Switzerland., Kustermann T; Roche Pharma Research and Early Development, NRD Biomarkers, Roche Innovation Center Basel, Basel, Switzerland., Mracsko EZ; Roche Pharma Research and Early Development, NRD Research, Roche Innovation Center Basel, Basel, Switzerland., Brockmann K; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany., Shariati N; F. Hoffmann-La Roche, Basel, Switzerland., Anzures-Cabrera J; Roche Products, Welwyn Garden City, UK., Zinnhardt B; Roche Pharma Research and Early Development, NRD Biomarkers, Roche Innovation Center Basel, Basel, Switzerland. |
